BridgeMD
New treatment option for Stroke
Official title Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome
ClinicalTrials.gov ID: NCT07173062
What this study is testing
- What it's testing
- The Western diet, rich in fat and sugar, contributes to cardiovascular risk and alters the body metabolism, specifically through the modulation of the microbiome. Microbiome is considered the "second genome", functioning as an endocrine-like organ.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 and older
You may be able to join if
- ≥50 years
- BMI ≥20 kg/m2
- History of stroke, coronary artery disease, myocardial infarction, peripheral artery disease, chronic kidney disease (eGFR \ 300 mg/g, or diabetes...
- No antibiotics in the previous 30 days
- If a woman, she must be a woman of non-childbearing potential. That is, she must be:
You likely can't join if
- Unwilling to sign the informed consent form (if the patient wants to participate but cannot sign for any reason, then a third-person testimony may...
- Involvement in the planning and/or conduct of the study (applies to both Investigator staff and/or staff at the study site).
- Participation in another clinical study with an investigational product during the last month.
- In participants recruited at Unidade Local de Saúde de São João, the exclusion criteria applied is estimated Glomerular Filtration Rate (eGFR) \<30...
See the full eligibility criteria
- ≥50 years
- BMI ≥20 kg/m2
- History of stroke, coronary artery disease, myocardial infarction, peripheral artery disease, chronic kidney disease (eGFR \ 300 mg/g, or diabetes mellitus
- No antibiotics in the previous 30 days
- If a woman, she must be a woman of non-childbearing potential. That is, she must be:
- Surgically sterilized (e.g. underwent hysterectomy, bilateral salpingectomy or bilateral oophorectomy);
- Clinically diagnosed infertile;
- In a post-menopausal state, defined as no menses for 12 months without an alternative medical cause.
- A woman patient of childbearing potential must have a negative serum pregnancy test at Visit 0 (Day 0) and must agree to use consistently and correctly (from 28 days prior to first study treatment administration until...
- Abstinence of heterosexual intercourse (when this is in line with preferred and usual lifestyle of the subject);
- Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable);
- Combined (oestrogen and progestogen containing) hormonal contraception associated with inhibition of ovulation (oral, intravaginal, transdermal);
- Intrauterine device;
- Intrauterine hormone-releasing system;
- Bilateral tubal occlusion;
- Vasectomized partner, who has received medical assessment of the surgical success, or clinically diagnosed infertile partner.
- Unwilling to sign the informed consent form (if the patient wants to participate but cannot sign for any reason, then a third-person testimony may sign/complete the informed consent form on the patient's behalf).
- Involvement in the planning and/or conduct of the study (applies to both Investigator staff and/or staff at the study site).
- Participation in another clinical study with an investigational product during the last month.
- In participants recruited at Unidade Local de Saúde de São João, the exclusion criteria applied is estimated Glomerular Filtration Rate (eGFR) \<30 ml/min/1.73m2 estimated with the CKD-EPI (2021) formula or dialysis...
The study team makes the final eligibility decision.
Where it's taking place
- Porto, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Porto, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.